Dose-dependent effects of lovastatin on cell cycle progression. Distinct requirement of cholesterol and non-sterol mevalonate derivatives
- 29 June 2001
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1532 (3), 185-194
- https://doi.org/10.1016/s1388-1981(01)00125-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Geranylgeranylpyrophosphate, a Metabolite of Mevalonate, Regulates the Cell Cycle Progression and DNA Synthesis in Human LymphocytesBiochemical and Biophysical Research Communications, 1997
- Geranylgeraniol Promotes Entry of UT-2 Cells into the Cell Cycle in the Absence of MevalonateExperimental Cell Research, 1997
- Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatinCancer Letters, 1996
- A Direct Role for Sterol Regulatory Element Binding Protein in Activation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase GeneOnline Journal of Public Health Informatics, 1996
- Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferationEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis y HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR miceCarcinogenesis: Integrative Cancer Research, 1994
- Effect of Pravastatin, a Potent 3‐Hydroxy‐3‐methylgliitaryl‐coenzyme A Reductase Inhibitor, on Survival of AH130 Hepatoma‐bearing RatsJapanese Journal of Cancer Research, 1992
- Regulation of the mevalonate pathwayNature, 1990
- Detection of Familial Hypercholesterolemia by Assaying Functional Low-Density-Lipoprotein Receptors on LymphocytesThe New England Journal of Medicine, 1986
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980